Healthcare | January 05, 2023
Viatris acquires Oyster Point Pharma and Famy Life Sciences
Acquisitions have the potential to add at least $1 billion in sales by 2028
Acquisitions have the potential to add at least $1 billion in sales by 2028
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Having a healthy gut is key as it permits the body to build a stronger immune system
The project will generate and supply green energy to fulfill about 50% present consumption of the company
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
As a result, Imago will become a subsidiary of Merck.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Acquisition expands Merck’s growing hematology portfolio
Subscribe To Our Newsletter & Stay Updated
